Literature DB >> 34216426

Extracellular Vesicle Nanoarchitectonics for Novel Drug Delivery Applications.

Shayna Sharma1, Mostafa Kamal Masud2,3,4, Yusuf Valentino Kaneti2, Prarthana Rewatkar5, Aayushi Koradia5, Md Shahriar A Hossain2,6, Yusuke Yamauchi2,3, Amirali Popat5,7, Carlos Salomon1,8.   

Abstract

Extracellular vesicles (EVs) can transfer intercellular messages in various (patho)physiological processes and transport biomolecules to recipient cells. EVs possess the capacity to evade the immune system and remain stable over long periods, identifying them as natural carriers for drugs and biologics. However, the challenges associated with EVs isolation, heterogeneity, coexistence with homologous biomolecules, and lack of site-specific delivery, have impeded their potential. In recent years, the amalgamation of EVs with rationally engineered nanostructures has been proposed for achieving effective drug loading and site-specific delivery. With the advancement of nanotechnology and nanoarchitectonics, different nanostructures with tunable size, shapes, and surface properties can be integrated with EVs for drug loading, target binding, efficient delivery, and therapeutics. Such integration may enable improved cellular targeting and the protection of encapsulated drugs for enhanced and specific delivery to target cells. This review summarizes the recent development of nanostructure amalgamated EVs for drug delivery, therapeutics, and real-time monitoring of disease progression. With a specific focus on the exosomal cargo, diverse drug delivery system, and biomimetic nanostructures based on EVs for selective drug delivery, this review also chronicles the needs and challenges of EV-based biomimetic nanostructures and provides a future outlook on the strategies posed.
© 2021 Wiley-VCH GmbH.

Keywords:  biomimetic nanostructures; drug delivery system; exosomes; extracellular vesicles (EVs); nanoarchitectonics; nanomedicine

Year:  2021        PMID: 34216426     DOI: 10.1002/smll.202102220

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  9 in total

Review 1.  Fibroblast growth factor receptor 1-bound extracellular vesicle as novel therapy for osteoarthritis.

Authors:  Bryan Gervais de Liyis; John Nolan; Made Agus Maharjana
Journal:  Biomedicine (Taipei)       Date:  2022-06-01

Review 2.  The emerging roles of exosomal long non-coding RNAs in bladder cancer.

Authors:  Qiang Liu
Journal:  J Cell Mol Med       Date:  2022-01-03       Impact factor: 5.310

3.  Engineering stem cells to produce exosomes with enhanced bone regeneration effects: an alternative strategy for gene therapy.

Authors:  Feiyang Li; Jun Wu; Daiye Li; Liuzhi Hao; Yanqun Li; Dan Yi; Kelvin W K Yeung; Di Chen; William W Lu; Haobo Pan; Tak Man Wong; Xiaoli Zhao
Journal:  J Nanobiotechnology       Date:  2022-03-15       Impact factor: 10.435

Review 4.  Bio-interactive nanoarchitectonics with two-dimensional materials and environments.

Authors:  Xuechen Shen; Jingwen Song; Cansu Sevencan; David Tai Leong; Katsuhiko Ariga
Journal:  Sci Technol Adv Mater       Date:  2022-03-30       Impact factor: 8.090

5.  Exosomes from Bone Marrow Mesenchymal Stem Cells with Overexpressed Nrf2 Inhibit Cardiac Fibrosis in Rats with Atrial Fibrillation.

Authors:  Lijuan Xu; Yingchao Fan; Liting Wu; Cui Zhang; Min Chu; Yuan Wang; Wenfang Zhuang
Journal:  Cardiovasc Ther       Date:  2022-03-15       Impact factor: 3.023

Review 6.  Molecule-to-Material-to-Bio Nanoarchitectonics with Biomedical Fullerene Nanoparticles.

Authors:  Xuechen Shen; Jingwen Song; Kohsaku Kawakami; Katsuhiko Ariga
Journal:  Materials (Basel)       Date:  2022-08-05       Impact factor: 3.748

Review 7.  Exosomes as Crucial Players in Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Yue Fei; Qi Liu; Na Peng; Guocan Yang; Ziwei Shen; Pan Hong; Shengjun Wang; Ke Rui; Dawei Cui
Journal:  J Immunol Res       Date:  2022-07-20       Impact factor: 4.493

8.  Rapid Isolation of Extracellular Vesicles Using a Hydrophilic Porous Silica Gel-Based Size-Exclusion Chromatography Column.

Authors:  Jun Yoshitake; Mayuko Azami; Haruka Sei; Daisuke Onoshima; Kumiko Takahashi; Akiyoshi Hirayama; Koji Uchida; Yoshinobu Baba; Takahiro Shibata
Journal:  Anal Chem       Date:  2022-09-27       Impact factor: 8.008

Review 9.  Recent Advances in the Application of Mesenchymal Stem Cell-Derived Exosomes for Cardiovascular and Neurodegenerative Disease Therapies.

Authors:  Zhimin Yang; Yanyu Li; Zihua Wang
Journal:  Pharmaceutics       Date:  2022-03-11       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.